Haixing Wang Selected Research

Icogenin

5/2009

Synthesis and cytotoxicities of icogenin analogues with disaccharide residues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haixing Wang Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 04/2002
4	Postmenopausal Osteoporosis 05/2022 - 11/2019
3	Inflammation (Inflammations) 11/2022 - 04/2016
3	Disease Progression 06/2022 - 03/2007
3	Osteoarthritis 06/2022 - 07/2018
3	Carcinoma (Carcinomatosis) 01/2022 - 04/2002
3	Esophageal Squamous Cell Carcinoma 09/2021 - 05/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2018 - 06/2015
2	Hypoxia (Hypoxemia) 11/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 05/2022 - 09/2017
2	Bone Fractures (Bone Fracture) 05/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 11/2019 - 07/2006
2	Bone Resorption 11/2019 - 03/2016
2	Breast Neoplasms (Breast Cancer) 09/2017 - 11/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2007 - 07/2006
2	Ovarian Neoplasms (Ovarian Cancer) 08/2004 - 04/2002
1	Right Ventricular Dysfunction 11/2022
1	Pulmonary Arterial Hypertension 11/2022
1	Vascular Diseases (Vascular Disease) 11/2022
1	Hypertrophy 06/2022
1	Osteoporotic Fractures 05/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2022
1	Embolic Stroke 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021
1	Residual Neoplasm 02/2021
1	Ventricular Fibrillation 01/2020
1	Cognitive Dysfunction 11/2019
1	Skin Neoplasms (Skin Cancer) 12/2018
1	Necrosis 08/2018
1	Leiomyomatosis 05/2016
1	Substance-Related Disorders (Drug Abuse) 04/2013
1	Infections 09/2006
1	Parkinson Disease (Parkinson's Disease) 07/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2002
3	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2018
3	Biological ProductsIBA 12/2019 - 03/2007
3	ProteomeIBA 03/2007 - 08/2004
3	Peptides (Polypeptides)IBA 11/2005 - 09/2002
2	LipidsIBA 11/2022 - 10/2021
2	MicroRNAs (MicroRNA)IBA 06/2022 - 07/2018
2	Estrogens (Estrogen)FDA Link 05/2022 - 01/2021
2	sesaminIBA 05/2022 - 12/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 08/2018
2	LigandsIBA 01/2022 - 12/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 05/2021
2	Coloring Agents (Dyes)IBA 11/2019 - 12/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2017
1	Therapeutic UsesIBA 11/2022
1	Semaxinib (SU5416)IBA 11/2022
1	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 11/2022
1	xylometazoline (stas)IBA 05/2022
1	Blood Group Antigens (Blood Groups)IBA 04/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	LB100IBA 09/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Chelating AgentsIBA 01/2021
1	Conditioned Culture MediaIBA 01/2021
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021
1	Sirtuin 3IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	Scopolamine (Hyoscine)FDA Link 11/2019
1	fascaplysineIBA 11/2019
1	Tartrate-Resistant Acid PhosphataseIBA 11/2019
1	Diphosphonates (Bisphosphonates)IBA 11/2019
1	IronIBA 12/2018
1	TitaniumIBA 08/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 08/2018
1	SphingosineIBA 08/2018
1	Interleukin-6 (Interleukin 6)IBA 08/2018
1	InterleukinsIBA 08/2018
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 08/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Epidermal Growth Factor (EGF)IBA 09/2017
1	Circulating Tumor DNAIBA 09/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	Advanced Glycation End ProductsIBA 03/2016
1	ParaffinIBA 06/2015
1	Growth Factor ReceptorsIBA 05/2015
1	Pharmaceutical PreparationsIBA 04/2013
1	IcogeninIBA 05/2009
1	Virulence Factors (Pathogenicity Factors)IBA 09/2006
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2006
1	3-nitrotyrosineIBA 07/2006
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2005

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2017
3	Lasers (Laser) 04/2022 - 09/2002
2	Precision Medicine 10/2021 - 12/2018
2	Neoadjuvant Therapy 02/2021 - 01/2020
1	Intra-Articular Injections 06/2022
1	Diathermy 10/2021
1	Drug Therapy (Chemotherapy) 09/2021
1	Bioreactors (Bioreactor) 01/2021
1	Hysterectomy 05/2016